Genes related to immunity identified in genome-wide association studies have been linked to the risk of sporadic AD, including those encoding complement receptor 1 (CR1), cluster of differentiation 33 (CD33), and triggering receptor expressed on myeloid cells 2 (TREM2) (Karch and Goate, 2015). The gene discussed is TREM2; the disease is Alzheimer disease.